Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
I know, that buy dildos online is cheaper.
Popular Articles

Biological Markers Identified That May Indicate Poor Breast Cancer Prognosis
A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation. Using data from the Health, Eating, Activity and Lifestyle (HEAL) study sponsored by the National Cancer Institute, part of the National Institutes of Health, the researchers found that breast cancer patients with elevated levels of C-reactive protein (CRP) and serum amyloid A (SAA) were approximately two to three times more likely to die sooner or have their cancer return than those patients who had lower levels of these proteins, regardless of the patient"s age, tumor stage, race, body mass index, or history of previous cardiovascular issues. The results of this study were published online, May 26, 2009, in the Journal of Clinical Oncology.
drugs without prescription
Docs Plan Strike, Issue Own Declaration Of Independence
On Independence Day, Doctors on Strike for Freedom in Medicine will take on the mission of preserving, protecting, and promoting freedom in healthcare. This nonprofit organization"s web site (http://www.doctorsonstrike.com) states that their most pressing goal is to mobilize doctors to go on strike against any new government healthcare plans. Their long-term objective is to supply healthcare providers with intellectual ammunition to win the "philosophical war" against statism in medicine.
News of the day
New Gene For Autism Gives Hope For Future
Scientists have discovered that abnormalities in a gene important for learning and memory are a cause of autism. The University of Aberdeen finding could hold the key to the future development of new treatments for autism - a brain development disorder which affects how a person communicates and relates to others. In a study published today in the Journal of Medical Genetics the researchers explain how their investigations into the gene EIF4E began with the study of one child with severe autism.
Endocrinology

BioTech Medics Announces SHBAN Antiviral Solution Undergoing H1N1 (Swine) Influenza Efficacy Testing

BioTech Medics, Inc. (PINKSHEETS: BMCS) announces that it has contracted to start conducting independent clinical testing of its patented SHBAN™ Antiviral Hand Sanitizer Solution to prove it kills the H1N1 (Swine) Influenza A virus in compliance with FDA and EPA standards. In 2007 BioTech conducted an independent study to determine the efficacy of virucidal SHBAN against Avian H5N1 Influenza NIBRG-14 Virus (also known as the Avian Bird Flu). BioTech reported that the SHBAN Solution had clinically proven its anti-viral properties and had topically killed the Avian Influenza virus. Significantly, SHBAN was proven non-toxic with "no cytotoxicity observed on the MDCK cell line after treatment." SHBAN is a bio-degradable product superior to most anti-viral and anti-bacterial disinfectants because 1) SHBAN is longer lasting, SHBAN does not evaporate within 15 seconds after application and cease working (like alcohol gels); 2) SHBAN is non-toxic when used as directed on humans and animals; 3) SHBAN is non-staining, non-bleaching; 4) SHBAN is non-flammable and 5) SHBAN has no harmful or toxic odors. Most hand sanitizer products cannot make all of these claims. BioTech currently sells a 3 oz SHBAN™ Go Anywhere Hand Atomizer Spray Bottle that complies with TSA carry-on travel regulations. SHBAN sales are up significantly in 2009. BioTech is releasing this Fall 1 oz and 16 oz bottles together with SHBAN Hand Wipe Towelettes. The World Health Organization (WHO) has declared the H1N1 Influenza a worldwide pandemic 6, so it is essential that people buying hand sanitizers know that SHBAN can prove that SHBAN kills the H1N1 Influenza Virus on the hands. SHBAN is protected under US Letters of Patent #5,514,808, #5,574,050, #5,679,711 and #5,585,391 and pending international patents. SHBAN is a trademark of BioTech Medics, Inc. BioTech is seeking and negotiating USA and foreign distributorships at this time. SHBAN™ in previous in vitro and in vivo testing has been evaluated for its antimicrobial properties against Staph. Aureus, Staph. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. BioTech Medics, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009